Your browser doesn't support javascript.
loading
Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States.
Chhatwal, Jagpreet; Mueller, Peter P; Chen, Qiushi; Kulkarni, Neeti; Adee, Madeline; Zarkin, Gary; LaRochelle, Marc R; Knudsen, Amy B; Barbosa, Carolina.
Afiliação
  • Chhatwal J; Institute for Technology Assessment, Massachusetts General Hospital, Boston.
  • Mueller PP; Harvard Medical School, Boston, Massachusetts.
  • Chen Q; Institute for Technology Assessment, Massachusetts General Hospital, Boston.
  • Kulkarni N; Institute for Technology Assessment, Massachusetts General Hospital, Boston.
  • Adee M; Harold and Inge Marcus Department of Industrial and Manufacturing Engineering, The Pennsylvania State University, University Park.
  • Zarkin G; Institute for Technology Assessment, Massachusetts General Hospital, Boston.
  • LaRochelle MR; Institute for Technology Assessment, Massachusetts General Hospital, Boston.
  • Knudsen AB; RTI International, Research Triangle Park, North Carolina.
  • Barbosa C; Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
JAMA Netw Open ; 6(6): e2314925, 2023 06 01.
Article em En | MEDLINE | ID: mdl-37294571
ABSTRACT
Importance In 2021, more than 80 000 US residents died from an opioid overdose. Public health intervention initiatives, such as the Helping to End Addiction Long-term (HEALing) Communities Study (HCS), are being launched with the goal of reducing opioid-related overdose deaths (OODs).

Objective:

To estimate the change in the projected number of OODs under different scenarios of the duration of sustainment of interventions, compared with the status quo. Design, Setting, and

Participants:

This decision analytical model simulated the opioid epidemic in the 4 states participating in the HCS (ie, Kentucky, Massachusetts, New York, and Ohio) from 2020 to 2026. Participants were a simulated population transitioning from opioid misuse to opioid use disorder (OUD), overdose, treatment, and relapse. The model was calibrated using 2015 to 2020 data from the National Survey on Drug Use and Health, the US Centers for Disease Control and Prevention, and other sources for each state. The model accounts for reduced initiation of medications for OUD (MOUDs) and increased OODs during the COVID-19 pandemic. Exposure Increasing MOUD initiation by 2- or 5-fold, improving MOUD retention to the rates achieved in clinical trial settings, increasing naloxone distribution efforts, and furthering safe opioid prescribing. An initial 2-year duration of interventions was simulated, with potential sustainment for up to 3 additional years. Main Outcomes and

Measures:

Projected reduction in number of OODs under different combinations and durations of sustainment of interventions.

Results:

Compared with the status quo, the estimated annual reduction in OODs at the end of the second year of interventions was 13% to 17% in Kentucky, 17% to 27% in Massachusetts, 15% to 22% in New York, and 15% to 22% in Ohio. Sustaining all interventions for an additional 3 years was estimated to reduce the annual number of OODs at the end of the fifth year by 18% to 27% in Kentucky, 28% to 46% in Massachusetts, 22% to 34% in New York, and 25% to 41% in Ohio. The longer the interventions were sustained, the better the outcomes; however, these positive gains would be washed out if interventions were not sustained. Conclusions and Relevance In this decision analytical model study of the opioid epidemic in 4 US states, sustained implementation of interventions, including increased delivery of MOUDs and naloxone supply, was found to be needed to reduce OODs and prevent deaths from increasing again.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles / 8_ODS3_consumo_sustancias_psicoactivas Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 2_sustancias_psicoativas / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases / 8_opioid_abuse Assunto principal: Overdose de Drogas / Overdose de Opiáceos / COVID-19 / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: JAMA Netw Open Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles / 8_ODS3_consumo_sustancias_psicoactivas Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 2_sustancias_psicoativas / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases / 8_opioid_abuse Assunto principal: Overdose de Drogas / Overdose de Opiáceos / COVID-19 / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: JAMA Netw Open Ano de publicação: 2023 Tipo de documento: Article
...